| Brand name |
Cerdelga
|
|---|---|
| المخاطر |
Drug-drug interaction: Use with CYP2D6 and/or CYP3A inhibitors, strong CYP3A inducers, P-gp or CYP2D6 substrates, Use of eliglustat in patients who are CYP2D6 indeterminate metabolizers or non-genotyped patients, Off label use in Gaucher disease type 2 and 3. |
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Sun 16 Aug 2026
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Official Reliable websites use HTTPS
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.